Gilead Sciences | GILD - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
AbbVie 23.96 0.93 2026-06
Agios Pharmaceuticals 3.56 0 2026-03
ALKERMES 135.81 96.48 2026-06
Alnylam Pharmaceuticals 75.64 4.4 2026-06
Amgen 18.07 1.77 2026-06
Biogen 23.23 9.53 2026-06
BioMarin Pharmaceutical 21.07 5.79 2026-06
Bristol-Myers Squibb 16.14 7.06 2026-06
Eli Lilly 32.9 7.37 2026-06
Gilead Sciences 13.51 4.2 2026-06
GlaxoSmithKline 10.63 4.24 2026-06
Glaxosmithkline 15.09 3.43 2026-03
Incyte 14.45 0.9 2026-06
J&J 29.43 4.9 2026-06
Merck 32.26 15.74 2026-06
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 22.1 5.99 2026-06
Novartis 22.41 2.24 2026-06
Pfizer 11.48 2.16 2026-06
PTC Therapeutics 8.76 1.22 2026-03
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Sanofi 18.96 7.12 2026-06
Sarepta Therapeutics 27.27 0 2026-03
United Therapeutics 19.15 1.27 2026-06
Vertex Pharmaceuticals 28.05 2.22 2026-06